India's drug regulator ordered Sun Pharma to stop making eye‑drops at its Assam plant after a joint inspection uncovered quality‑system failures and a recall of 332 batches.
India's drug regulator ordered Sun Pharma to stop making eye‑drops at its Assam plant after a joint inspection uncovered quality‑system failures and a recall of 332 batches.